RET-IN-1
Product Specifications
UNSPSC Description
RET-IN-1 is a RET kinase inhibitor extracted from patent WO2018071447A1, Compound Example 552, has IC50s of 1 nM, 7 nM, and 101 nM for RET (WT), RET (V804M) , and RET (G810R), respectively [1].
Target Antigen
RET
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ret-in-1.html
Solubility
10 mM in DMSO
Smiles
N#CC1=C2C(C3=NC=C(N4CC(C5)N(CC6=CC=C(OC)N=C6)C5C4)N=C3)=CC(OC[C@H]7CNCCO7)=CN2N=C1
Molecular Weight
553.61
References & Citations
[1]Steven W A, et al. Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors. WO2018071447A1.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-112950/RET-IN-1-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-112950/
Clinical Information
No Development Reported
CAS Number
2222755-14-6
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7013008-01 0.02 mg
Recombinant Staphylococcus aureus Protein CrcB homolog 2 (crcB2)
Ask
View Details 
MBS7013008-02 0.1 mg
Recombinant Staphylococcus aureus Protein CrcB homolog 2 (crcB2)
Ask
View Details MBS7013008-03 5x 0.1 mg
Recombinant Staphylococcus aureus Protein CrcB homolog 2 (crcB2)
Ask
View Details 